These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 938544)

  • 1. Thermodynamics of fatty acid anion displacement of warfarin and phenylbutazone from human albumin.
    Rippie EG
    Biochem Pharmacol; 1976 May; 25(10):1215-6. PubMed ID: 938544
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone.
    O'Reilly RA
    Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-dependent effects of fatty acids on warfarin binding to albumin.
    Wilding G; Feldhoff RC; Vesell ES
    Biochem Pharmacol; 1977 Jun; 26(12):1143-6. PubMed ID: 560850
    [No Abstract]   [Full Text] [Related]  

  • 5. Optical studies into the nature of the high affinity binding site of human serum albumin for phenylbutazone.
    Maes V; Hoebeke J; Vercruysse A; Kanarek L
    Mol Pharmacol; 1979 Jul; 16(1):147-53. PubMed ID: 481416
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
    He J; Shibukawa A; Tokunaga S; Nakagawa T
    J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

  • 9. The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.
    Solomon HM; Schrogie JJ; Williams D
    Biochem Pharmacol; 1968 Jan; 17(1):143-51. PubMed ID: 5638549
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of coumarins to site I of human serum albumin. Effect of the fatty acids.
    Zatón AM; Ferrer JM; Ruiz de Gordoa JC; Marquínez MA
    Chem Biol Interact; 1995 Jul; 97(2):169-74. PubMed ID: 7606814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin binding to human albumin.
    Lecomte M; Zini R; d'Athis P; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):23-8. PubMed ID: 467465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry polyacrylamide batch method for studying drug protein binding.
    Julkunen RJ; Himberg JJ
    Arzneimittelforschung; 1976 Apr; 26(4):560-3. PubMed ID: 989013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chain length dependency of fatty acid and carbamate binding to serum albumin.
    Brown NA; Wilson AG; Bridges JW
    Biochem Pharmacol; 1982 Dec; 31(24):4019-29. PubMed ID: 7159478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperativity of warfarin binding with human serum albumin induced by free fatty acid anion.
    Chakrabarti SK
    Biochem Pharmacol; 1978 Mar; 27(5):739-43. PubMed ID: 656112
    [No Abstract]   [Full Text] [Related]  

  • 16. Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry.
    Aki H; Yamamoto M
    J Pharm Sci; 1994 Dec; 83(12):1712-6. PubMed ID: 7891299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs.
    Sellers EM; Koch-Weser J
    Ann N Y Acad Sci; 1971 Jul; 179():213-25. PubMed ID: 5285376
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR; Bowmer CJ; Yates MS
    Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    Maes V; Engelborghs Y; Hoebeke J; Maras Y; Vercruysse A
    Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of temperature on binding of warfarin by human serum albumin.
    Oester YT; Keresztes-Nagy S; Mais RF; Becktel J; Zaroslinski JF
    J Pharm Sci; 1976 Nov; 65(11):1673-7. PubMed ID: 994000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.